Clinicians lack reliable tools to predict how neurodegenerative diseases will progress in individual patients, in part because there are few biological markers that can accurately reflect brain health in living people.

As a Schmidt Science Fellow, Alicia will develop radioactive imaging agents, called PET tracers, to detect diseased neurons in the brain. These tracers will combine antibody technology with radiochemistry to target proteins that identify non-functional neurons.

With this approach, Alicia aims to improve the diagnosis and monitoring of neurodegenerative diseases and deliver therapeutics specifically to affected neurons, enabling earlier intervention and better response to therapy.

Alicia will pivot from Neuroscience to Chemical Engineering